4.8 Article

CRISPR/Cas12a collateral cleavage activity for simple and rapid detection of protein/small molecule interaction

Journal

BIOSENSORS & BIOELECTRONICS
Volume 194, Issue -, Pages -

Publisher

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2021.113587

Keywords

Protein; small molecule interaction; CRISPR; Cas; Collateral cleavage; Fluorescent biosensor

Funding

  1. Mid-career Researcher Support Program [2018R1A2A1A05022355]
  2. BioSynergy Research Project of the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT) of South Korea [2015M3A9C4070484]

Ask authors/readers for more resources

This study presents a novel method to identify protein/small molecule interactions utilizing the CRISPR/Cas12a system, successfully determining two model interactions at very low concentrations. The technique allows for rapid and simple detection of target proteins by measuring fluorescence signals. The practical applicability of this method was confirmed by reliably detecting target proteins in human serum samples.
To realize the full potential of the CRISPR/Cas system and expand its applicability up to the detection of mo-lecular interactions, we herein describe a novel method to identify protein/small molecule interactions by uti-lizing the CRISPR/Cas12a collateral cleavage activity. This technique employs a single-stranded activator DNA modified with a specific small molecule, which would switch on the CRISPR/Cas12a collateral cleavage activity upon binding to crRNA within the CRISPR/Cas12a system. When the target protein binds to the small molecule on the activator DNA, the bound protein sterically hinders the access of the activator DNA to crRNA, thereby promoting less collateral cleavage activity of CRISPR/Cas12a. As a consequence, fewer reporter probes nearby are cleaved to produce accordingly reduced fluorescence signals in response to target protein. Based on this unique design principle, the two model protein/small molecule interactions, streptavidin/biotin and anti-digoxigenin/digoxigenin, were successfully determined down to 0.03 nM and 0.09 nM, respectively, with a fast and simple detection workflow (11 min). The practical applicability of this method was also verified by reliably detecting target streptavidin spiked in heterogeneous human serum. This work would provide great insight to construct novel strategies to identify protein/small molecule interaction by making the most of the CRISPR/Cas12a system beyond its superior capabilities in genome editing and molecular diagnostics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available